Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Capital Expenditures (2018 - 2021)

Historic Capital Expenditures for ENDRA Life Sciences (NDRA) over the last 4 years, with Q1 2021 value amounting to $45000.0.

  • ENDRA Life Sciences' Capital Expenditures rose 10134.23% to $45000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was $45000.0, marking a year-over-year decrease of 4026.52%. This contributed to the annual value of $16000.0 for FY2024, which is 5278.01% down from last year.
  • As of Q1 2021, ENDRA Life Sciences' Capital Expenditures stood at $45000.0, which was up 10134.23% from $64850.0 recorded in Q4 2020.
  • In the past 5 years, ENDRA Life Sciences' Capital Expenditures ranged from a high of $100000.0 in Q3 2018 and a low of -$11867.0 during Q3 2020
  • For the 4-year period, ENDRA Life Sciences' Capital Expenditures averaged around $32991.0, with its median value being $30353.5 (2019).
  • Within the past 5 years, the most significant YoY rise in ENDRA Life Sciences' Capital Expenditures was 32660.81% (2020), while the steepest drop was 6906.95% (2020).
  • Over the past 4 years, ENDRA Life Sciences' Capital Expenditures (Quarter) stood at $100000.0 in 2018, then crashed by 61.64% to $38357.0 in 2019, then surged by 69.07% to $64850.0 in 2020, then crashed by 30.61% to $45000.0 in 2021.
  • Its Capital Expenditures stands at $45000.0 for Q1 2021, versus $64850.0 for Q4 2020 and -$11867.0 for Q3 2020.